FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Provectus Biopharmaceuticals Data Presented At ESMO 2014 Congress Show Ablative, Bystander Effects Of PV-10
September 29, 2014
Provectus Biopharmaceuticals’ PV-10 Clinical Data on Melanoma Now Available for European Society for Medical Oncology 2014 Congress
September 24, 2014
Provectus’ Intralesional Pv-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting
September 23, 2014
Provectus Biopharmaceuticals Appoints Christopher Kaplan to Its Strategic Advisory Board
September 22, 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Provectus Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PVCT
July 13, 2014
Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, and Sinopharm A-THINK Pharmaceutical Co., Ltd.
August 18, 2014
Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly Conference Calls on Thursday, August 7, 2014
August 06, 2014
Provectus Biopharmaceuticals’ PV-10 Clinical Data on the Treatment of Melanoma to Be Presented at European Society for Medical Oncology 2014 Congress
July 23, 2014
Medidata Appoints Mike Capone COO; PV-10 Data At Esmo 2014 Show
September 30, 2014
from Blogs - TalkMarkets
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here